Skip to main content
logo
PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
296.00
+14.00 (4.96%)
Nov 5, 2026, 3:40 PM WIB

IDX:DGNS Financials Overview

Millions IDR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
180,752166,624163,072145,696192,886302,182
Revenue Growth
14.41%2.18%11.93%-24.46%-36.17%64.97%
Gross Profit
84,46878,28372,07459,31293,759148,555
Operating Income
2,9866,1291,924-15,15117,09981,429
Net Income
1,1212,937747.44-13,65612,66564,304
Earnings Per Share
0.872.350.60-10.9210.0051.84
EPS Growth
-292.95%---80.71%-1.60%

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
12,7379,9335,16911,94130,55351,227
Total Debt
71,51277,14670,38254,71413,2795,277
Net Cash (Debt)
-58,775-67,214-65,213-42,77317,27445,950
Net Cash Growth
-----62.41%229.33%
Net Cash Per Share
-45.49-53.77-52.17-34.2213.8237.04

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,83710,65827,29913,184-5,95658,875
Capital Expenditures
-2,337-8,073-43,394-38,324-34,096-67,841
Free Cash Flow
-499.262,585-16,095-25,141-40,052-8,966
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
46.73%46.98%44.20%40.71%48.61%49.16%
Operating Margin
1.65%3.68%1.18%-10.40%8.87%26.95%
Pretax Margin
1.33%3.24%0.53%-9.32%8.99%27.56%
Profit Margin
0.62%1.76%0.46%-9.37%6.57%21.28%
FCF Margin
-0.28%1.55%-9.87%-17.26%-20.77%-2.97%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
341.1278.31326.11-24.0814.48
P/FCF Ratio
-88.99----
PS Ratio
2.221.381.502.111.583.08